CoChat

Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo

Open access
Poli, Maura, Asperti, Michela, Naggi, Annamaria, Campostrini, Natascia, Girelli, Domenico, Corbella, Michela, Benzi, Marina, Besson-Fournier, Celine, Coppin, Helene, Maccarinelli, Federica, Finazzi, Dario, Arosio, Paolo · 2014 · Blood
Cited by 69

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Key Points: Chemically modified nonanticoagulant heparins are strong inhibitors of hepcidin expression in normal and Bmp6−/− mice. These heparins abolish hepcidin induction caused by LPS, a model of inflammation, and are candidates for treatment of inflammatory anemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2013-07-515221

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 34

  1. Arosio, 2002, Ferritin, iron homeostasis, and oxidative damage., Free Radic Biol Med, 33, 457, 10.1016/S0891-5849(02)00842-0 · DOI · Paper page
  2. Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization., Science, 306, 2090, 10.1126/science.1104742 · DOI · Paper page
  3. Samad, 2005, DRAGON, a bone morphogenetic protein co-receptor., J Biol Chem, 280, 14122, 10.1074/jbc.M410034200 · DOI · Paper page
  4. Silvestri, 2009, Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia., Blood, 113, 5605, 10.1182/blood-2008-12-195594 · DOI · Paper page
  5. Roth, 2009, [BMP6: a key player in iron metabolism]., Med Sci (Paris), 25, 678, 10.1051/medsci/2009258-9678 · DOI
  6. Chung, 2010, Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone., FASEB J, 24, 2093, 10.1096/fj.09-152561 · DOI · Paper page
  7. Sun, Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation., 10.1002/ajh.23110 · DOI · Paper page
  8. Sakurai, 1993, [Purification of bone morphogenetic protein and investigation of its effects on osteoblastic cell line UMR108]., Kokubyo Gakkai Zasshi, 60, 169, 10.5357/koubyou.60.169 · doi:10.5357/koubyou.60.169
  9. Jiao, 2007, Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells., J Biol Chem, 282, 1080, 10.1074/jbc.M513414200 · DOI · Paper page
  10. Ruppert, 1996, Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity., Eur J Biochem, 237, 295, 10.1111/j.1432-1033.1996.0295n.x · DOI · Paper page
  11. Kanzaki, 2008, Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor., J Cell Physiol, 216, 844, 10.1002/jcp.21468 · DOI
  12. Zhao, 2006, Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2., J Biol Chem, 281, 23246, 10.1074/jbc.M511039200 · DOI · Paper page
  13. Takada, 2003, Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins., J Biol Chem, 278, 43229, 10.1074/jbc.M300937200 · DOI · Paper page
  14. Brkljacic, 2013, Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity., Int Orthop, 37, 529, 10.1007/s00264-012-1714-3 · DOI
  15. Casu, 2002, Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans., Semin Thromb Hemost, 28, 335, 10.1055/s-2002-34302 · DOI
  16. Turnbull, 2001, Heparan sulfate: decoding a dynamic multifunctional cell regulator., Trends Cell Biol, 11, 75, 10.1016/S0962-8924(00)01897-3 · DOI · Paper page
  17. Mulloy, 2006, Cytokines and proteoglycans: an introductory overview., Biochem Soc Trans, 34, 409, 10.1042/BST0340409 · DOI
  18. Ritchie, 2011, SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis., Clin Cancer Res, 17, 1382, 10.1158/1078-0432.CCR-10-2476 · DOI · Paper page
  19. Presta, 2003, Heparin derivatives as angiogenesis inhibitors., Curr Pharm Des, 9, 553, 10.2174/1381612033391379 · DOI · Paper page
  20. Casu, 2010, Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer., Matrix Biol, 29, 442, 10.1016/j.matbio.2010.04.003 · DOI
  21. Naggi, 2005, Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting., J Biol Chem, 280, 12103, 10.1074/jbc.M414217200 · DOI · Paper page
  22. Conrad, 1992, Structural analysis of periodate-oxidized heparin., Adv Exp Med Biol, 313, 31, 10.1007/978-1-4899-2444-5_3 · doi:10.1007/978-1-4899-2444-5_3
  23. Mousa, 2002, Anticoagulants in thrombosis and cancer: the missing link., Semin Thromb Hemost, 28, 45, 10.1055/s-2002-20559 · DOI
  24. Castagna, 2010, Hepcidin assay in serum by SELDI-TOF-MS and other approaches., J Proteomics, 73, 527, 10.1016/j.jprot.2009.08.003 · DOI
  25. Dongiovanni, 2013, Dietary iron overload induces visceral adipose tissue insulin resistance., Am J Pathol, 182, 2254, 10.1016/j.ajpath.2013.02.019 · DOI · Paper page
  26. Tjalsma, 2011, Mass spectrometry analysis of hepcidin peptides in experimental mouse models., PLoS ONE, 6, e16762, 10.1371/journal.pone.0016762 · DOI · Paper page
  27. Roetto, 2010, Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues., Blood, 115, 3382, 10.1182/blood-2009-09-240960 · DOI · Paper page
  28. Cooke, 2013, A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates., Blood, 122, 3054, 10.1182/blood-2013-06-505792 · DOI · Paper page
  29. Malmström, 2012, Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function., J Histochem Cytochem, 60, 916, 10.1369/0022155412459857 · DOI · Paper page
  30. Casu, 2001, Structure and biological interactions of heparin and heparan sulfate., Adv Carbohydr Chem Biochem, 57, 159, 10.1016/S0065-2318(01)57017-1 · DOI · Paper page
  31. Naggi, Glycol-splitting as a device for modulating inhibition of growth factors and heparanase by heparin and heparin derivatives., 10.1016/B978-008044859-6/50017-4 · doi:10.1016/b978-008044859-6/50017-4
  32. Casu, 2004, Undersulfated and glycol-split heparins endowed with antiangiogenic activity., J Med Chem, 47, 838, 10.1021/jm030893g · DOI
  33. Kragh, 2005, Non-anti-coagulant heparins: a promising approach for prevention of tumor metastasis (review). [review], Int J Oncol, 27, 1159
  34. Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance., J Clin Invest, 117, 1933, 10.1172/JCI31342 · DOI · Paper page

Cited by

See all 69

Metadata

Authors
Poli, M., Asperti, M., Naggi, A., Campostrini, N., Girelli, D., Corbella, M., Benzi, M., Besson-Fournier, C., Coppin, H., Maccarinelli, F., Finazzi, D., & Arosio, P.
Venue
Blood
Published
2014-03-06
Volume
123
Issue
10
Pages
1564-1573
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1968893403
Cited by
69
References
24
FWCI
6.12
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. https://app.cochat.ai/papers/10.1182/blood-2013-07-515221
The paper
Poli, M., Asperti, M., Naggi, A., Campostrini, N., Girelli, D., Corbella, M., Benzi, M., Besson-Fournier, C., Coppin, H., Maccarinelli, F., Finazzi, D., & Arosio, P. (2014). Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. Blood. https://doi.org/10.1182/blood-2013-07-515221

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.